ArticleRheumatology advances in practice2026
Managing fatigue in inflammatory arthritis: a real-world evaluation of program length and delivery.
Article in Rheumatology advances in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Fatigue is a significant yet often overlooked symptom in rheumatic diseases, impacting sleep, mental health and daily functioning. The aim of this study was to evaluate the effectiveness of a fatigue management program (FMP) developed in NHS Lothian, comparing a 4-week format to a 7-week format. The study also examines the impact of in-person Methods: A retrospective analysis was conducted on 22 FMPs delivered between February 2020 and March 2024. Patients with inflammatory arthritis were referred to the program, with 142 patients participating. Initially, sessions were in-person, but due to COVID-19, the program transitioned online and was shortened from 7 to 4 weeks in response to high demand. Standardised patient-reported outcome measures (PROMs) assessed fatigue severity, fatigue impact, mental health and sleep quality. A control group ( Results: Both the 4-week and 7-week FMPs significantly improved fatigue severity ( Conclusion: A 4-week FMP is as effective as a 7-week program, making it a more accessible option. Virtual delivery provides an equally beneficial alternative to in-person sessions. These findings support the use of shorter, remotely delivered FMPs as a scalable, resource-efficient approach to fatigue management in rheumatology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.